Authors
Latest:
Transfer Responsibility with SaaS: TRADE OUTDATED LIMS TECHNOLOGY AND IT HASSLES FOR ZERO-TOUCH MAINTENANCEAs today’s labs continue to evolve, the software solutions that support them must too. Likewise, laboratory and organization leadership must be open to the advancements available to them from modern technologies. In this white paper, learn how a SaaS-based LIMS modernization program optimizes data management, fosters collaboration, and improves decision-making to stay at the forefront of scientific innovation.
Latest:
Unveiling CQA Insights for mRNA, LNPs, and Viral Vectors by SEC and MALS With Novel 1000 Å Ultrawide Pore Particle ColumnsWebinar Date/Time: Thu, Sep 5, 2024 11:00 AM EDT
Latest:
Advanced analytical workflow solutions for monitoring critical quality attributes of monoclonal antibodiesIn this webcast we will present Agilent samples to answers workflow solutions for monoclonal antibody characterization. The presentation covers analytical strategies for monitoring CQAs. We will focus on main quality attributes such as charge variants, aggregation, glycosylation, host cell protein impurities and post-translational modifications. Live: Europe: Wednesday, Feb. 5, 2020 at 2pm GMT | 3pm CET US: Wednesday, Feb. 5, 2020 at 2pm EST | 1pm CST | 11am PST On demand available after final airing until Feb. 5, 2021 Register free
Latest:
Industry Consortiums Work to Tackle COVID-19As COVID-19 continues to spread, industry leaders are banding together to stop the disease in its tracks.
Latest:
High-Throughput Multi-Product Liquid Chromatography for Characterization of Monoclonal AntibodiesAn approach to biopharmaceutical development that combines Quality by Design with a suite of visual informatics tools to reduce scale-up risks.
Latest:
Stability Indicating Methods for Aluminum Adsorbed Vaccine ProductsThe authors provide an introduction to aluminum adsorbed vaccines, review studies of antigen stability, and propose test methods for the analysis of aluminum vaccine release and stability analysis.
Latest:
Methods Accelerate Biosimilar AnalysisEffective application of mass-spectrometry tools can optimize biosimilar analysis, reducing development time and cost.
Latest:
Improving Oligonucleotide AnalysisOligonucleotides, which are classified as both small molecules and biomolecules, pose unique analytical challenges. High-resolution mass spectrometry is becoming a method of choice for their development.
Latest:
Garantire la compliance e l’integrità dei dati: servizi Agilent CrossLab Enterprise per la conformità del tuo laboratorioUna panoramica sulle richieste degli enti regolatori rispetto al data integrity e ad un corretto approccio alla Computer System Validation. Come Agilent può diventare un prezioso alleato nella gestione della conformità all’interno del laboratorio. Mercoledì, 23 ottobre 2019 alle ore 14 CEST Disponibile su richiesta fino al 23 ottobre 2020 Register free
Latest:
Opportunity to Mitigate Risk with ValPlus™ CertificationValPlus™ provides pharmaceutical manufacturers increased confidence in the cleanliness of the tubing products they use in critical applications. This whitepaper describes ValPlus™ testing protocols, results obtained, and value to manufacturers.
Latest:
Fermentation Process Technology Transfer for Production of a Recombinant Vaccine ComponentThe authors describe challenges faced in transfer and scale-up of a fermentation process.
Latest:
Biologic Standards in the Pharmacopoeias: An UpdateAwareness of recently implemented—or ongoing—advances by the pharmacopoeias can help biotherapeutic manufacturers remain compliant with current requirements.
Latest:
Biologic Standards in the Pharmacopoeias: An UpdateAwareness of recently implemented—or ongoing—advances by the pharmacopoeias can help biotherapeutic manufacturers remain compliant with current requirements.
Latest:
Plants As an Innovative and Accelerated Vaccine-Manufacturing SolutionA plant-based expression system could provide greater speed and capacity at a comparatively low cost.
Latest:
Outsourcing of Nonclinical Studies for Drug Development: Tips and TrendsLearning to think with the end in mind will help clients and their selected CRO to design and conduct the right studies.
Latest:
Outsourcing of Nonclinical Studies for Drug Development: Tips and TrendsLearning to think with the end in mind will help clients and their selected CRO to design and conduct the right studies.
Latest:
Outsourcing of Nonclinical Studies for Drug Development: Tips and TrendsLearning to think with the end in mind will help clients and their selected CRO to design and conduct the right studies.
Latest:
Supplier-Change Management for Drug-Product ManufacturersAn effective supplier-initiated change management process is discussed.
Latest:
Logistics of Cleaning ValidationA guide for improving the planning and preparation of future validation work.
Latest:
Novel Hydrophobic Interaction Chromatography Resins for Next Generation Biotherapeutic ChallengesDesigned to solve complex downstream separation and purification challenges for many biotherapeutic modalities, a suite of hydrophobic chromatography resins (POROS HIC) has been developed that cover a wide range of hydrophobicity.
Latest:
Novel Hydrophobic Interaction Chromatography Resins for Next Generation Biotherapeutic ChallengesDesigned to solve complex downstream separation and purification challenges for many biotherapeutic modalities, a suite of hydrophobic chromatography resins (POROS HIC) has been developed that cover a wide range of hydrophobicity.
Latest:
Novel Hydrophobic Interaction Chromatography Resins for Next Generation Biotherapeutic ChallengesDesigned to solve complex downstream separation and purification challenges for many biotherapeutic modalities, a suite of hydrophobic chromatography resins (POROS HIC) has been developed that cover a wide range of hydrophobicity.
Latest:
Angiopoietins: Novel Targets for Anti-angiogenesis TherapyThe authors review the angiopoietin pathway as an alternative for safer and more efficacious anti-angiogenic therapeutics.
Latest:
Applying Lessons Learned from the Semiconductor IndustryApplying lessons of raw materials’ characterization and supply-chain control from the semiconductor industry allow more rigorous control of the biopharmaceutical manufacturing process.
Latest:
Applying Lessons Learned from the Semiconductor IndustryApplying lessons of raw materials’ characterization and supply-chain control from the semiconductor industry allow more rigorous control of the biopharmaceutical manufacturing process.
Latest:
Using TEM-Based Image Analysis to Validate the Presence of HA Spikes on Influenza VLPsThe authors of this study demonstrate an innovative method that is useful and complements traditional HA assays.
